Literature DB >> 33331603

Time interval between onset of symptoms and COVID-19 testing in Brazilian state capitals, August 2020.

Francisca Elisângela Teixeira Lima1, Nila Larisse Silva de Albuquerque1, Sabrina de Souza Gurgel Florencio1, Maria Gabriela Miranda Fontenele1, Ana Paula Oliveira Queiroz2, Glaubervania Alves Lima1, Lanese Medeiros de Figueiredo3, Silvia Maria Costa Amorim2, Lorena Pinheiro Barbosa1.   

Abstract

OBJECTIVE: To analyze notifications of flu-like syndrome according to the time interval between onset of symptoms and testing for COVID-19.
METHODS: This was a cross-sectional study using records of flu-like syndrome cases containing results of COVID-19 diagnostic tests in the Brazilian state capitals and Federal District, held on the e-SUS Notifica system, from March 1st, 2020 to August 18th, 2020. The time interval between symptom onset and testing was compared using the ANOVA test, classifying it according to test adequacy/timeliness.
RESULTS: Taking 1,942,514 notifications, average time between symptom onset and testing was 10.2 days (±17.1). Among those tested, females (55.1%), people aged 20-39 years (43.8%), and the Southeast region of Brazil (43.0%) predominated. 58.8% of IgM ELISA tests were performed at an adequate time while 68.0% of rapid antigen tests were not performed at an adequate time.
CONCLUSION: Inadequacy was found between symptom onset and time taken to test for COVID-19 in the Brazilian regions.

Entities:  

Year:  2020        PMID: 33331603     DOI: 10.1590/S1679-4974202100010002

Source DB:  PubMed          Journal:  Epidemiol Serv Saude        ISSN: 1679-4974


  7 in total

1.  COVID-19 testing, timeliness and positivity from ICMR's laboratory surveillance network in India: Profile of 176 million individuals tested and 188 million tests, March 2020 to January 2021.

Authors:  Manickam Ponnaiah; Rizwan Suliankatchi Abdulkader; Tarun Bhatnagar; Jeromie Wesley Vivian Thangaraj; Muthusamy Santhosh Kumar; Ramasamy Sabarinathan; Saravanakumar Velusamy; Yogesh Sabde; Harpreet Singh; Manoj Vasanth Murhekar
Journal:  PLoS One       Date:  2021-12-03       Impact factor: 3.240

2.  QDS-COVID: A visual analytics system for interactive exploration of millions of COVID-19 healthcare records in Brazil.

Authors:  Juan Carlos Carbajal Ipenza; Noemi Maritza Lapa Romero; Melina Loreto; Nivan Ferreira Júnior; João Luiz Dihl Comba
Journal:  Appl Soft Comput       Date:  2022-06-03       Impact factor: 8.263

3.  Tracking the emergence of disparities in the subnational spread of COVID-19 in Brazil using an online application for real-time data visualisation: A longitudinal analysis.

Authors:  Paul Mee; Neal Alexander; Philippe Mayaud; Felipe de Jesus Colón González; Sam Abbott; Andreza Aruska de Souza Santos; André Luís Acosta; Kris V Parag; Rafael H M Pereira; Carlos A Prete; Ester C Sabino; Nuno R Faria; Oliver J Brady
Journal:  Lancet Reg Health Am       Date:  2022-01

4.  COVID-19 contact tracing in Belgium: main indicators and performance, January - September 2021.

Authors:  Kristiaan Proesmans; Sharon Hancart; Toon Braeye; Sofieke Klamer; Emmanuel Robesyn; Achille Djiena; Frances De Leeuw; Romain Mahieu; Alex Dreuw; Naima Hammami; Dirk Wildemeersch; Laura Cornelissen; Dieter Van Cauteren
Journal:  Arch Public Health       Date:  2022-04-13

5.  COVID-19 ICU demand forecasting: A two-stage Prophet-LSTM approach.

Authors:  Dalton Borges; Mariá C V Nascimento
Journal:  Appl Soft Comput       Date:  2022-06-17       Impact factor: 8.263

6.  An evaluation index system for regional mobile SARS-CoV-2 virus nucleic acid testing capacity in China: a modified Delphi consensus study.

Authors:  Dong-Sheng Di; Jian-Li Zhang; Mu-Hong Wei; Hao-Long Zhou; Yuan Cui; Ru-Yi Zhang; Ye-Qing Tong; Jun-An Liu; Qi Wang
Journal:  BMC Health Serv Res       Date:  2022-08-24       Impact factor: 2.908

7.  Influence of age on the effectiveness and duration of protection of Vaxzevria and CoronaVac vaccines: A population-based study.

Authors:  Thiago Cerqueira-Silva; Vinicius de Araújo Oliveira; Viviane S Boaventura; Julia M Pescarini; Juracy Bertoldo Júnior; Tales Mota Machado; Renzo Flores-Ortiz; Gerson O Penna; Maria Yury Ichihara; Jacson Venâncio de Barros; Mauricio L Barreto; Guilherme Loureiro Werneck; Manoel Barral-Netto
Journal:  Lancet Reg Health Am       Date:  2021-12-22
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.